LCM Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
LCM Capital Management's VRTX Position: Q3 2026 in Review
LCM Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 1.3% in Q3 2026, buying an estimated $8.19K and bringing the position to 1,212 shares worth $634K. The position accounts for 0.27% of the portfolio, ranked #50.
LCM Capital Management first reported a position in VRTX in Q1 2023 and has held it in 15 quarters since. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- LCM Capital Management held 1,212 shares of Vertex Pharmaceuticals worth $634K as of Q3 2026.
- LCM Capital Management bought 16 Vertex Pharmaceuticals shares in Q3 2026, an estimated $8.19K.
- Vertex Pharmaceuticals made up 0.27% of LCM Capital Management's portfolio in Q3 2026, its #50 holding.
- LCM Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 15 quarters since.
- 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on LCM Capital Management's 13F filing for Q3 2026, filed 20 Oct 2026.